Enterprise Value

176.5M

Cash

202.6M

Avg Qtr Burn

-31.92M

Short % of Float

16.08%

Insider Ownership

50.66%

Institutional Own.

40.60%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Posoleucel Details
Viral infection, Adenovirus

Phase 3

Data readout

Posoleucel Details
Human herpesvirus 6, Epstein-Barr virus, Adenovirus, BK virus, Cytomegalovirus

Phase 3

Data readout

Posoleucel Details
BK virus, Kidney transplantation

Phase 2

Update

Phase 1/2

Data readout

ALVR106 Details
Parainfluenza virus, Human metapneumovirus, Respiratory syncytial virus, Influenza

Phase 1/2

Interim update